We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

190 hedge funds and large institutions have $805M invested in Immunogen Inc in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 62 increasing their positions, 57 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more call options, than puts

Call options by funds: $18.4M | Put options by funds: $6.38M

9% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 57

7% less funds holding

Funds holding: 204190 (-14)

20% less capital invested

Capital invested by funds: $1B → $805M (-$198M)

32% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 31

Holders
190
Holders Change
-14
Holders Change %
-6.86%
% of All Funds
3.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
62
Reduced
57
Closed
31
Calls
$18.4M
Puts
$6.38M
Net Calls
+$12M
Net Calls Change
+$8.64M
Name Holding Trade Value Shares
Change
Change in
Stake
ASRS
101
Arizona State Retirement System
Arizona
$221K +$6.46K +1,515 +3%
Principal Financial Group
102
Principal Financial Group
Iowa
$215K +$9.43K +2,213 +4%
RJFSA
103
Raymond James Financial Services Advisors
Florida
$211K +$20.6K +4,832 +10%
CIC
104
Cornercap Investment Counsel
Georgia
$205K +$73.5K +17,246 +48%
Cambridge Investment Research Advisors
105
Cambridge Investment Research Advisors
Iowa
$197K +$2.71K +636 +1%
AWM
106
Apollon Wealth Management
South Carolina
$192K +$213K +50,000 New
ACM
107
Aquatic Capital Management
Illinois
$188K +$209K +49,000 New
SG Americas Securities
108
SG Americas Securities
New York
$179K +$40.1K +9,419 +25%
JCM
109
Jacobi Capital Management
Pennsylvania
$177K
MNBTD
110
Moody National Bank Trust Division
Texas
$176K +$42K +9,851 +27%
EAM
111
Erste Asset Management
Austria
$174K
RJA
112
Raymond James & Associates
Florida
$174K +$24.1K +5,658 +14%
SEI Investments
113
SEI Investments
Pennsylvania
$173K +$192K +45,121 New
Russell Investments Group
114
Russell Investments Group
United Kingdom
$172K -$31.5K -7,400 -14%
Qube Research & Technologies (QRT)
115
Qube Research & Technologies (QRT)
United Kingdom
$163K +$181K +42,516 New
ProShare Advisors
116
ProShare Advisors
Maryland
$156K -$22.6K -5,308 -12%
Canada Life
117
Canada Life
Manitoba, Canada
$153K +$126K +29,596 +295%
DT
118
Diversified Trust
Tennessee
$150K
Public Employees Retirement Association of Colorado
119
Public Employees Retirement Association of Colorado
Colorado
$134K
Axa
120
Axa
France
$126K +$140K +32,900 New
BC
121
BIT Capital
Germany
$123K +$137K +32,130 New
ECM
122
ExodusPoint Capital Management
New York
$120K +$133K +31,268 New
Zurich Cantonal Bank
123
Zurich Cantonal Bank
Switzerland
$116K -$13.7K -3,206 -10%
GCP
124
GSA Capital Partners
United Kingdom
$114K +$127K +29,800 New
Stifel Financial
125
Stifel Financial
Missouri
$109K +$1.68K +394 +1%

IMGN Hedge Fund Activity: Q1 2023 in Review

190 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2023, worth a combined $805M — down 20% from $1B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of IMGN and 21 opened new positions — a net loss of 10 holders — while 57 trimmed existing stakes and 62 added.

The largest buyer was Janus Henderson Group, adding an estimated $56.7M. The largest seller was Deerfield Management, exiting entirely with an estimated $31.5M sold.

  • 190 institutional investors held Immunogen Inc (IMGN) as of Q1 2023, down from 204 in Q4 2022.
  • Funds reported $805M of Immunogen Inc stock for Q1 2023, down 20% quarter-over-quarter.
  • 21 funds opened new Immunogen Inc positions in Q1 2023 and 31 closed out, a net change of -10 holders.
  • The largest Immunogen Inc buyer in Q1 2023 was Janus Henderson Group, an estimated $56.7M added.
  • The largest Immunogen Inc seller in Q1 2023 was Deerfield Management, an estimated $31.5M sold.

Based on aggregated 13F filings for Q1 2023.